Order Article Reprints

Toropainen E, Fraser-Miller SJ, Novakovic D, Del Amo EM, Vellonen K-S, Ruponen M, Viitala T, Korhonen O, Auriola S, Hellinen L, et al. Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin. Pharmaceutics. 2021; 13(4):452. https://doi.org/10.3390/pharmaceutics13040452

Toropainen, Elisa, Sara J. Fraser-Miller, Dunja Novakovic, Eva M. Del Amo, Kati-Sisko Vellonen, Marika Ruponen, Tapani Viitala, Ossi Korhonen, Seppo Auriola, Laura Hellinen, and et al. 2021. "Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin" Pharmaceutics 13, no. 4: 452. https://doi.org/10.3390/pharmaceutics13040452

Toropainen, E., Fraser-Miller, S. J., Novakovic, D., Del Amo, E. M., Vellonen, K.-S., Ruponen, M., Viitala, T., Korhonen, O., Auriola, S., Hellinen, L., Reinisalo, M., Tengvall, U., Choi, S., Absar, M., Strachan, C., & Urtti, A. (2021). Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin. Pharmaceutics, 13(4), 452. https://doi.org/10.3390/pharmaceutics13040452